Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Whittaker (London, United Kingdom), H. Mullerova (London, United Kingdom), D. Jarvis (London, United Kingdom), N. Barnes (London, United Kingdom), P. Jones (London, United Kingdom), C. Compton (London, United Kingdom), S. Kiddle (Cambridge, United Kingdom), J. Quint (London, United Kingdom). Late Breaking Abstract - Inhaled corticosteroids (ICS), blood eosinophils (EOS), and FEV1 decline in patients with Chronic Obstructive Pulmonary Disease in a large UK primary healthcare setting. 1163

Member's Comments

No comment yet.

Related content which might interest you: Rate of FVC decline in a primary care UK Chronic Obstructive Pulmonary Disease (COPD) population Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 One year change in health status in patients with stable Chronic Obstructive Pulmonary Disease (COPD) under long-acting bronchodilators treatment Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 Obstructive sleep apnea accelerates decline in FEV1 in asthmatic patients Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014 Late Breaking Abstract - High blood neutrophils are associated with increased exacerbations and mortality in Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Small airways dysfunction is associated with poorer control in asthmatics with a preserved FEV1 Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Are normal lung sounds on aucultation associated with FEVI and FVC volume changes in Asthma, Chronic Obstructive Pulmonary Disease (COPD) and Interstitial lung disease (ILD)? Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications Year: 2019 Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study Source: Eur Respir J 2013; 41: 548-555 Year: 2013 Effectiveness of indacaterol with or without tiotropium in patients with moderate or severe chronic obstructive pulmonary disease (COPD) - the GOLDEN II study Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014 Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT) Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco Year: 2020 Stability of blood eosinophils in stable Chronic Obstructive Pulmonary Disease: a retrospective study in primary care. Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Oscillating positive expiratory pressure (oPEP) therapy in chronic obstructive pulmonary disease and bronchiectasis Source: International Congress 2014 – Best posters in chronic care Year: 2014 Blood eosinophilia and the number of exacerbations in COPD patients Source: International Congress 2014 – Diagnosing and managing asthma and COPD in primary care Year: 2014 Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Health care resource utilization (HCRU) in early and late diagnosed Chronic Obstructive Pulmonary Disease (COPD) patients in UK primary care Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 178s Year: 2002 Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Clinical consequences of late Chronic Obstructive Pulmonary Disease (COPD) diagnosis compared to early diagnosis in UK primary care Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients  – nationwide data from Denmark Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes Year: 2021 Correlations between Lung Clearance Index (LCI) measurements and spirometry in Chronic Obstructive Pulmonary Disease (COPD). Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease Year: 2019